Cite
HARVARD Citation
Wechsler, M. et al. (2022). Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study. Lancet. 10 (7), pp. 650-660. [Online].